Residual disease after mastectomy
Lancet Oncol
.
2020 Nov;21(11):e499.
doi: 10.1016/S1470-2045(20)30542-8.
Authors
Nigel J Bundred
1
,
David Dodwell
2
,
James R Bundred
3
,
Ramsey I Cutress
4
Affiliations
1
Manchester University NHS Foundation Trust, Wythenshawe, Manchester M23 9LT, UK. Electronic address: bundredn@manchester.ac.uk.
2
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
3
Leeds Teaching Hospital NHS Trust, Leeds, UK.
4
University Hospital Southampton, Southampton, UK.
PMID:
33152291
DOI:
10.1016/S1470-2045(20)30542-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / surgery
Humans
Mastectomy*
Mastectomy, Segmental
Neoplasm, Residual
Grants and funding
21133/CRUK_/Cancer Research UK/United Kingdom
MC_U137686858/MRC_/Medical Research Council/United Kingdom
PB-PG-0712-28108/DH_/Department of Health/United Kingdom
RP-PG-0608-10168/DH_/Department of Health/United Kingdom